| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |